Accenture vs Omnicom
ACN and OMC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACN and OMC compare
Accenture is the larger company, worth 7.1 times as much as Omnicom ($167B against $23.7B).
Omnicom grew revenue faster over the last twelve months (54.1% versus 6.5% for Accenture).
Accenture keeps more of each dollar of sales as profit, with a net margin of 11.3% compared with 2.8% at Omnicom.
Both pay dividends: Accenture yields 2.0% and Omnicom 3.7%.
Accenture scores higher on the StockData Score (19 against 8 for Omnicom), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACN | OMC |
|---|---|---|
| Size and price | ||
| Market cap | $167B | $23.7B |
| Share price | $249.95 | $86.84 |
| Change, 1 year | 3.0% | 17.5% |
| Change, 5 years | −32.4% | 29.4% |
| Beta (5Y) | 0.93 | 0.74 |
| Employees | 814K | 120K |
| StockData Score | ||
| Total score | 19 (better) | 8 |
| Valuation score | 4 (better) | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 6 (better) | 2 |
| Health score | 5 (better) | 2 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 18.4× | – |
| P/S | 2.3× | 1.0× (better) |
| P/B | 5.3× | 2.4× (better) |
| EV/EBITDA | 14.5× | 13.6× (better) |
| P/FCF | 14.4× | 8.3× (better) |
| PEG | 2.31 | – |
| FCF yield | 6.9% | 12.1% (better) |
| Fair value | $305.31 | $83.05 |
| Margin of safety | 18.1% (better) | −4.6% |
| Growth | ||
| Revenue growth (TTM) | 6.5% | 54.1% (better) |
| Revenue growth, 5Y average | 8.0% (better) | 5.6% |
| Net income growth (TTM) | 9.0% (better) | −47.2% |
| EPS growth (TTM) | 11.6% | – |
| EPS growth, 5Y average | 8.2% | – |
| Profitability | ||
| Gross margin | 32.0% (better) | 12.6% |
| Operating margin | 15.4% (better) | 6.4% |
| Net margin | 11.3% (better) | 2.8% |
| FCF margin | 15.7% (better) | 11.6% |
| Return on equity | 26.7% (better) | 9.7% |
| Return on invested capital | 31.8% (better) | 9.2% |
| Financial health | ||
| Debt / equity | 0.32 (better) | 0.95 |
| Net debt / EBITDA | −0.24 | 2.59 (better) |
| Interest coverage | 37.6× (better) | 3.5× |
| Current ratio | 1.43 (better) | 0.91 |
| Altman Z-score | 4.60 (better) | 1.24 |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 2.0% | 3.7% (better) |
| Payout ratio | – | 119% |
| Years of dividend growth | – | 1 |
| Dividend growth, 5Y average | – | 2.2% |
| Buyback yield | 4.5% | 15.2% (better) |
| Shareholder yield | 6.5% | 18.9% (better) |
| Ownership | ||
| Held by institutions | 73.1% | 109% |
| Held by insiders | 0.04% | 1.00% |
| Insider net buying, 12 months | −$11.9M | −$238K (better) |
| Superinvestors holding | 5 | – |
| Short interest, % of float | 3.2% | 9.0% |
Go deeper
- ACN stock overview
- ACN income statement
- ACN valuation and score
- OMC stock overview
- OMC income statement
- OMC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.